Plasma Exchange
Plasma Exchange is a medical device with 35 clinical trials. Currently 4 active trials ongoing. Historical success rate of 77.8%.
Success Metrics
Based on 14 completed trials
Phase Distribution
Phase Distribution
2
Early Stage
5
Mid Stage
8
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
70.0%
14 of 20 finished
30.0%
6 ended early
4
trials recruiting
35
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Immunoadsorption Versus Plasma Exchange for Treatment of Guillain-Barré Syndrome (GBS)
Efficacy and Safety of Cytokine Adsorption and Plasma Exchange in Patients With ACLF and Sepsis
Novel Treatments in Improving Renal Outcomes in Light Chain Cast Nephropathy
Transplant Antibody-Mediated Rejection: Guiding Effective Treatments
Trial of Plasma Exchange for Acute Renal Failure at the Onset of Myeloma
Clinical Trials (35)
Immunoadsorption Versus Plasma Exchange for Treatment of Guillain-Barré Syndrome (GBS)
Efficacy and Safety of Cytokine Adsorption and Plasma Exchange in Patients With ACLF and Sepsis
Novel Treatments in Improving Renal Outcomes in Light Chain Cast Nephropathy
Transplant Antibody-Mediated Rejection: Guiding Effective Treatments
Trial of Plasma Exchange for Acute Renal Failure at the Onset of Myeloma
Efficacy and Safety of Therapeutic Plasma Exchange vs Standard Medical Therapy in Severe Autoimmune Hepatitis.
Daily Versus Alternate Day Plasma Exchange in Wilson Disease With Acute Liver Failure in Children
Comparison Between Centrifugation Based and Membrane Based Plasma Exchange
rATG Versus rATG Combined With Intravenous Immunoglobulin (IVIG) Induction Immunosuppression in HLA Incompatible Transplantation (INHIBIT)
Efficacy of Plasma Exchange Therapy vs Standard Medical Therapy in Severe Alcoholic Hepatitis With High Discriminant Function
An Efficacy and Safety Study of Imlifidase in Treatment of Antibody-Mediated Rejection in Kidney Transplant Patients
An Open-label Randomized Controlled Trial Comparing the Role of Therapeutic Plasma-exchange in Ameliorating Secondary Organ Dysfunctions in Patients With ACLF and Develop Biomarkers of Treatment Response
Plasma Exchange vs Conservative Management in Non-severe Acute Hypertriglyceridemic Pancreatitis
Plasma Exchange in Patients With COVID-19 Disease and Invasive Mechanical Ventilation: a Randomized Controlled Trial
Efficacy of Addition of Fecal Microbiota Transplant (FMT) and Plasma Exchange to Tenofovir in Comparison to Monotherapy With Tenofovir in ACLF-HBV
Risk Factors and the Effect of Plasma Exchange on Prognosis of Pregnancy-related Thrombotic Microangiopathies
Efficacy and Safety of Plasma Exchange With Albutein® 5% in Participants With Amyotrophic Lateral Sclerosis
Thromboelastography Guides a Multicentre Cluster Controlled Study of Plasma Exchange for Hepatitis B Associated Acute-on-chronic Liver Failure
Mini-pool Intravenous Immunoglobulin (MP-IVIG) in Guillain-Barré Syndrome
Plasma Exchange and Glucocorticoids for Treatment of Anti-Neutrophil Cytoplasm Antibody (ANCA) - Associated Vasculitis
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 35